Abstract
Rapid growth of the left ventricle of the newborn pig heart can be restrained by treating piglets with the angiotensin converting enzyme inhibitor, enalapril maleate. This reduced rate of growth is reflected in vitro by reduced rates of ribosome formation and protein synthesis, and may be due to decreased availability of angiotensin II (All), a potentially hypertrophic agent; decreased numbers of All receptors; increased availability of bradykinin, a potentially antihypertrophic agent; or reduced hemodynamic load on the left ventricle. Because enalapril decreases degradation of bradykinin, the role of bradykinin as an inhibitor of cardiac growth in the newborn heart was investigated. Addition of 1 × 10−5 M bradykinin and 1 × 10−6 Menalapril to the perfusate of isolated hearts from 2 day old piglets did not significantly alter heart rate, contents of ATP or creatine phosphate or rates of ribosome formation or protein synthesis during 1 h of perfusion. Similarly, exposure of myocytes isolated from the left ventricular free wall of piglets to 5 × 10−6 M bradykinin for 72 h did not alter the rate of [3H]-phenylalanine incorporation into total protein. The reduced rate of left ventricular growth in vivo caused by enalapril administration was not reversed by simultaneous treatment with the specific bradykinin receptor antagonist, HOE 140. HOE 140 alone did not alter ventricular growth as compared to hearts from untreated piglets. In summary, these results demonstrate that the reduced rate of left ventricular growth in vivo and the reduced rate of ribosome formation and protein synthesis in the left ventricle in vitro after enalapril treatment of piglets is not the result of an inhibitory effect of bradykinin on cardiac growth.
Similar content being viewed by others
References
Baker KM, Chernin MI, Wixson SA, Aceto JF: Renin-angiotensin system involvement in pressure overload cardiac hypertrophy in rats. Am J Physiol 259: H324-H332, 1990
Beinlich CJ, Baker KM, White GJ, Morgan HE: Control of growth in neonatal pig heart. Am J Physiol 261: (Suppl 1) 3–7, 1991
Beinlich CJ, Rissinger CJ, Morgan HE: Mechanisms of rapid growth in the neonatal pig heart. J Mol Cell Cardiol 27: 273–281, 1995
Morgan HE, Baker KM: Cardiac hypertrophy. Mechanical, neural and endocrine dependence. Circ 83: 13–25, 1991
Linz W, Schölkens BA: Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors. J Cardiovas Pharm 20 (Suppl 9): S83-S90, 1992
Linz W, Schölkens BA: A specific B2-bradykinin receptor antagonist HOE 140 abolishes antihypertrophic effect of ramipril. Br J Pharmacol 105:771–772, 1992
Linz W, Weimer G, Schölkens BA: Bradykinin prevents left ventricular hypertrophy in rats. J Hypertension 11 (Suppl 5): S96-S97, 1993
Beinlich CJ, White GJ, Baker KM, Morgan HE: Angiotensin II and left ventricular growth in newborn pig heart. J. Mol Cell Cardiol 23: 1031–1038, 1991
Beinlich CJ, Baker KM, Morgan HE: α-Adrenergic receptor agonists stimulate ribosome formation in hearts from enalapril-treated piglets. J Mol Cell Cardiol 25: 395–406, 1993
Munro HN, Fleck A: The determination of nucleic acids. In: D. Glick (ed.) Methods in Biochemical Analysis. Wiley, New York, 1966, 14: pp 114–176
Tsanev R, Markov GG: Substances interfering with spectrophotometric estimation of nucleic acids and their elimination by the two-wave length method. Biochim Biophys Acta 42: 442–452, 1960
Lowry OH, Rosenbrough NJ, Farr ASL, Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–275, 1951
Camacho J, Peterson C, White G., Morgan HE: Accelerated ribosome formation and growth in neonatal pig heart. Am J Physiol 258: C86-C91, 1990
Peterson C, Whitman V, Watson PA, Schuler HG, Morgan HE: Mechanisms of differential growth of heart ventricles in newborn pigs. Circ Res 64: 360–369, 1989
Chua BHL, Russo LA, Gordon EE, Kleinhans BJ, Morgan HE: Faster ribosome synthesis induced by elevated aortic pressure in rat heart. Am J Physiol 252: C323-C327, 1987
Wollenberger A, Ristau O, Schoffa G: Eine einfache Technik der extrem schnellen Abkuhlung größerer Gewebestucke. Arch Ges Physiol 270: 399–412, 1969
Beinlich CJ, Morgan HE: Development of a cell culture system for studies of the growth of neonatal pig cardiomyocytes. In: Y. Yazaki (ed.) Cardiac Development and Gene Regulation, Excerpta Medica, Tokyo, 1995, pp 65–75
Smolich JJ, Soust M, Berger PJ, Walker AM: Indirect relation between rises in oxygen consumption and left ventricular output at birth in lambs. Cite Res 71: 443–450, 1992
Riemenschneider TA, Brenner RA, Mason DT: Maturational changes in myocardial contractile state of newborn lambs. Pediatr Res 5: 349–356, 1981
Anderson PAW, Glick KL, Manring A, Crenshaw C Jr: Developmental changes in cardiac contractility in fetal and post natal sheep: in vitro and in vivo. Am J Physiol 247: H371-H379, 1984
Comline RS, Silver M: The composition of fetal and maternal blood during parturition in the ewe. J Physiol (London) 222: 233–256, 1972
Davidson D: Circulating vasoactive substances and hemodynamic adjustments at birth in lambs. J Appl Physiol 63: 676–684, 1987
Padbury JF, Martinez AM: Sympathoadrenal system activity at birth: Integration of postnatal adaption. Semin Perinatol 12: 163–172, 1988
Kirkpatrick SE, Covell JM, Friedman WF: A new technique for the continuous assessment of fetal and neonatal cardiac performance. Am J Obstet Gynecol 116: 963–972, 1973
Morgan HE, Xenophomos XP, Haneda T, McGlaughin S, Watson PA: Stretch-anabolism transduction. J Appl Cardiol 4: 415–422, 1989
Sadoshima J, Izumo S: Molecular characterization of angiotensin IIinduced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413–423, 1993
Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977–984, 1993
Speth RC, Khosla MC, Speth MM, Ferrario CM: Rat (Ile5) but not bovine (Val5) angiotensin raises plasma norepinephrine in rats. Hypertension 3 (Suppl 11): II25-II29, 1981
Campbell DJ, Kladis A, Duncan AM: Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23: 439–449, 1994
Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henke St, Breipohl G, König W, Knolle J, Schölkens BA: HOE 140 a new potent and long acting bradykinin antagonist: in vivo studies. Br J Pharmacol 102: 774–777, 1991
Rhaleb NE, Yang XP, Scicli AG, Carretero OA: Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension 23 (Part 2): 865–868, 1994
Minshall RD, Nakamura F, Becker RP, Rabito SF: Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circ Res 76: 773–780, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beinlich, C.J., Rissinger, C.J., Vitkauskas, K.J. et al. Role of bradykinin in the antihypertr. ophic effects of enalapril in the newborn pig heart. Mol Cell Biochem 163, 77–83 (1996). https://doi.org/10.1007/BF00408643
Issue Date:
DOI: https://doi.org/10.1007/BF00408643